METALLOIDS IN ASYMMETRIC AND STEREOSELECTIVE SYNTHESIS

不对称和立体选择性合成中的类金属

基本信息

项目摘要

The research proposed herein focuses upon the development of new synthetic methodology which utilizes the special directive properties of metalloidal groups to orchestrate a high degree of control on the stereochemical course which is followed in a given chemical reaction. These principles are examined with respect to classic reactions such as the Wittig olefination, asymmetric hydroboration and the directed aldol condensation. The synthesis of Z-vinylsilanes in high isomeric purity from acylsilane/ylide combinations provides the basis for new routes to trans-alkenol pheromones, and thus, illustrates the novel, complementary role played by acylsilanes compared to aldehydes in the Wittig olefination which give predominately cis products. Extension of this approach to acyltin derivatives should provide access to stereodefined vinyltin compounds which can be converted to one of the chiral aggregation pheromone components of the European elm bark beetle through an asymmetric hydroboration. Moreover, through the asymmetric hydroboration of stereo-defined beta, beta- disubstituted vinylsilanes, a new, general route to optically- active anti-inflammatory agents such as Naproxen, Ibuprofen and six related commercial products is proposed. The approach utilizes the dissymmetry of silyl vs hydrogen substituents at the reaction site to impart diastereofacial selectivity in the process which gives asymmetric induction at the more remote beta carbon. Another aspect of the research takes advantage of several new aspects of stereo-defined silylated vinylboranes which either can be converted to enolboranes which are expected to give threo-selective crossed aldol products with aldehydes, reactions which lead to polyoxygenated antibiotics. On the other hand, new concepts in sterically-directed crossed aldol reactions of acylsilanes either from the standpoint of E-enolates of acylsilanes or from enolate- acylsilane combinations are expected to enhance the scope of the now-general aldol route to these antibiotics. Thus, the thrust of this study is to decisively demonstrate by example the important role that can be played by a metalloidal group in directing the precise course followed in important chemical reactions. Moreover, in the reactions selected for study herein, the basis for further developments will be laid so that the chemical principles learned can be applied to new synthetic targets in the future.
本文提出的研究重点是开发新的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN A SODERQUIST其他文献

JOHN A SODERQUIST的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN A SODERQUIST', 18)}}的其他基金

NOVEL REAGENTS AND CATALYSTS FOR CHIRAL PHARMACEUTICALS
手性药物的新型试剂和催化剂
  • 批准号:
    6601183
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
NOVEL REAGENTS AND CATALYSTS FOR CHIRAL PHARMACEUTICALS
手性药物的新型试剂和催化剂
  • 批准号:
    6631250
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
NOVEL REAGENTS AND CATALYSTS FOR CHIRAL PHARMACEUTICALS
手性药物的新型试剂和催化剂
  • 批准号:
    6564511
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
NOVEL REAGENTS AND CATALYSTS FOR CHIRAL PHARMACEUTICALS
手性药物的新型试剂和催化剂
  • 批准号:
    6609859
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
NOVEL REAGENTS AND CATALYSTS FOR CHIRAL PHARMACEUTICALS
手性药物的新型试剂和催化剂
  • 批准号:
    6472787
  • 财政年份:
    2001
  • 资助金额:
    --
  • 项目类别:
NOVEL REAGENTS AND CATALYSTS FOR CHIRAL PHARMACEUTICALS
手性药物的新型试剂和催化剂
  • 批准号:
    6325846
  • 财政年份:
    2000
  • 资助金额:
    --
  • 项目类别:
NOVEL REAGENTS AND CATALYSTS FOR CHIRAL PHARMACEUTICALS
手性药物的新型试剂和催化剂
  • 批准号:
    6219056
  • 财政年份:
    1999
  • 资助金额:
    --
  • 项目类别:
NOVEL REAGENTS AND CATALYSTS FOR CHIRAL PHARMACEUTICALS
手性药物的新型试剂和催化剂
  • 批准号:
    6271547
  • 财政年份:
    1998
  • 资助金额:
    --
  • 项目类别:
NOVEL REAGENTS AND CATALYSTS FOR CHIRAL PHARMACEUTICALS
手性药物的新型试剂和催化剂
  • 批准号:
    6107134
  • 财政年份:
    1998
  • 资助金额:
    --
  • 项目类别:
NOVEL REAGENTS AND CATALYSTS FOR CHIRAL PHARMACEUTICALS
手性药物的新型试剂和催化剂
  • 批准号:
    6240025
  • 财政年份:
    1997
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
  • 批准号:
    10448926
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
  • 批准号:
    10491861
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
  • 批准号:
    10675535
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
  • 批准号:
    EP/S021868/1
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
    Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
  • 批准号:
    529840-2018
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
    Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
  • 批准号:
    1403724
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
  • 批准号:
    1403697
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
  • 批准号:
    131690
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
    Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
  • 批准号:
    131338
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
    Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
  • 批准号:
    429734-2011
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
    Experience Awards (previously Industrial Undergraduate Student Research Awards)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了